GCC2 as a New Early Diagnostic Biomarker for Non-Small Cell Lung Cancer

SIMPLE SUMMARY: Lung cancer, including non-small cell lung cancer, is the leading cause of cancer-related death worldwide. A better prognosis is associated with early diagnosis of lung cancer patients. Although annual screening guidelines for lung cancer are recommended, using various tools such as...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeong, Hyesun, Choi, Byeong Hyeon, Park, JinA, Jung, Jik-Han, Shin, Hyunku, Kang, Ka-Won, Quan, Yu Hua, Yu, Jewon, Park, Ji-Ho, Park, Yong, Choi, Yeonho, Kim, Hyun Koo, Hong, Sunghoi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582534/
https://www.ncbi.nlm.nih.gov/pubmed/34771645
http://dx.doi.org/10.3390/cancers13215482

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582534/
https://www.ncbi.nlm.nih.gov/pubmed/34771645
http://dx.doi.org/10.3390/cancers13215482

Ejemplares similares